0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Dyskinesia and Akathisia Induced by Ethosuximide

ABDOLREZA EHYAI, MD; ANTHONY W. KILROY, MD; GERALD M. FENICHEL, MD
Am J Dis Child. 1978;132(5):527-528. doi:10.1001/archpedi.1978.02120300087020.
Text Size: A A A
Published online

Ethosuximide (Zarotin) was introduced in 1958 for the treatment of petit mal epilepsy1 and has since been found useful in the control of minor motor seizures. We report the case histories of two children in whom a syndrome characterized by motor restlessness (akathisia) and purposeless movements of the tongue, jaw, face, and extremities (dyskinesia) developed 12 hours after the first ingestion of ethosuximide. Among the various side effects attributed to this drug, this reaction must be exceedingly rare as we have been able to find only one previous report.2

Report of Cases.—Case 1.—The patient was developing normally and was in good health, when at the age of 8 months, a prolonged generalized seizure occurred in association with a fever of 38 C. Phenobarbital, diazepam, and paraldehyde were given. His physical examination was normal afterwards, as were blood chemistries, spinal fluid, and roentgenogram of the skull. An

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();